More articles from Idiopathic interstitial pneumonias

Impact of Bifidobacterium longum BB536 on nausea caused by pirfenidone in a mouse model of pellagra
Koji Kuronuma, Natsumi Susai, Takeshi Yoshioka, Atsushi Saito, Hirofumi Chiba

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3895; DOI: 10.1183/13993003.congress-2023.PA3895
CycloZ reduces inflammation in bleomycin-induced idiopathic pulmonary fibrosis model mice.
Seoyeong Baek, Dohyun Lee, Jongsu Jeon, Onyu Park, Xiaoxu Li, Alessia Demasi, Gayeong Hur, Seung-Hyo Lee, Johan Auwerx, Hoe-Yune Jung

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3911; DOI: 10.1183/13993003.congress-2023.PA3911
Preclinical evaluation of Ezetimibe for repurposing to pulmonary fibrosis.
Chanho Lee, Se Hyun Kwak, Jisu Han, Ju Hye Shin, Yu Seol Lee, Jeong Su Park, Beom Jin Lim, Jin Gu Lee, Young Sam Kim, Song Yee Kim, Soo Han Bae

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3913; DOI: 10.1183/13993003.congress-2023.PA3913
Regenerative capacity of alveolar type 2 cells is proportionally reduced following disease progression in IPF-derived organoid cultures
Hyeon Kyu Choi, Ju Hye Shin, Mi Hwa Shin, Ala Woo, Sang Hoon Lee, Eun Young Kim, Hyo Sup Shim, Ha Eun Kim, Joo Hyeon Lee, Chul Hoon Kim, Moo Suk Park

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3898; DOI: 10.1183/13993003.congress-2023.PA3898
A multicenter study of extracellular vesicles profile in bronchoalveolar lavage from patients affected by IPF, HP and sarcoidosis
Miriana d'Alessandro, Sara Gangi, Piera Soccio, Elisabet Cantó, Ruben Osuna, Laura Bergantini, Paolo Cameli, Gaia Fabbri, Sara Croce, Giulia Scioscia, Giorgia Moriondo, Giusy Montuori, Matteo Fanetti, Fabrizio Mezzasalma, Diego Castillo, Donato Lacedonia, Silvia Vidal, Elena Bargagli

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3902; DOI: 10.1183/13993003.congress-2023.PA3902
Abnormal phosphorylation of Per2 induces myofibroblast transformation and promotes the development of pulmonary fibrosis
Mei Chen, Lian Liu

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3899; DOI: 10.1183/13993003.congress-2023.PA3899
A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman primates and human lung tissue
Tingting Yuan, Szymon Klossowski, Maria Afrazi, Holly Hamilton, Julia Hegge, James Hamilton, Tao Pei, Erik Bush

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3909; DOI: 10.1183/13993003.congress-2023.PA3909
Fcor/FOXO1 axis regulates GLUT1-mediated mitochondrial oxidative stress and metabolic reprogramming in angiotensin II-induced fibroblast activation
Wei Wang, Ying Meng

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3896; DOI: 10.1183/13993003.congress-2023.PA3896
Imatinib treatment for fibrotic lung disorders: ex vivo assessment on human lungs.
Cecilia Bagnera, Sara Bozzini, Eleonora Bozza, Matteo Della Zoppa, Silvia Mancinelli, Federica Briganti, Giulio Melloni, Federica Meloni

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3907; DOI: 10.1183/13993003.congress-2023.PA3907
Use of invasive lung function assessment (DSI/Buxco) to quantify changes in lung function parameters in a rat bleomycin model of lung fibrosis.
Mary McElroy, Rachel Macfarlane, Jennifer Dowie, Kirsten Maclellan, Shyloh Solomon, James Baily

European Respiratory Journal Sep 2023, 62 (suppl 67) PA3904; DOI: 10.1183/13993003.congress-2023.PA3904

Main menu

User menu

Search

More articles from Idiopathic interstitial pneumonias

Pages

Contact us